The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.42
Bid: 4.42
Ask: 4.46
Change: 0.02 (0.45%)
Spread: 0.04 (0.905%)
Open: 4.515
High: 4.515
Low: 4.38
Prev. Close: 4.40
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NEW FACEAPI PRODUCT RELEASE

26 Aug 2008 08:33

RNS Number : 9816B
Seeing Machines Limited
26 August 2008
 



26 August 2008

Seeing Machines Limited

("Seeing Machines" or the "Company")

SEEING MACHINES ANNOUNCES NEW FACEAPI PRODUCT RELEASE

Seeing Machines (AIM: SEE), a leading developer of advanced computer based imaging software systems, yesterday released a new version of its faceAPI product, a face tracking toolkit for Original Equipment Manufacturers (OEM's) and application developers that turns a web camera into a 3D face tracking device.  The product was released at NVISION 08 NVIDIA's visual computing conference held in San Jose California this week.

"The new release of the faceAPI boasts a large number of new features and improvements. We have delivered on requests from our partners and customers, and then some" said Nick Langdale-Smith, Director of Sales and Marketing for Seeing Machines. "One of the major additions is the unique ability to track lip and eyebrow movements, enabling games and virtual worlds to read a user's facial expression, as well as head orientation and movement". 

Dr Nick Cerneaz, CEO of Seeing Machines commenting on the release said "This release of the faceAPI product is a very important part of our long term strategy. We expect this version of the faceAPI to be the springboard for the commercial success of this product".

Further information about Seeing Machines and faceAPI can be obtained from the Company web site: www.seeingmachines.com.

--- ENDS ---

Enquiries:

Seeing Machines Limited

Grant Thornton UK LLP

Parkgreen Communications

Nick Cerneaz, CEO

Fiona Owen

Paul McManusHelen Westaway

+61 (0) 2 6125 6501

+44 (0) 20 7383 5100

+44 (0) 20 7851 7480

www.seeingmachines.com

  Notes to editors:

About Seeing Machines

Seeing Machines is an award winning Technology Company which focuses on vision based human machine interfaces. Formed in 2000 in CanberraAustralia, Seeing Machines purpose is to commercialize its computer-vision across a range of industries and applications. 

Seeing Machines delivers advanced computer vision solutions for researchers and developers in human factors, transportation safety, entertainment, computer human interaction, robotics and medical research. 

Seeing Machines computer vision systems are able to measure the orientation and position of a human head, estimate eye-gaze direction, detect eye blinks and track other facial features. This functionality is achieved entirely though visual means, using video cameras connected to advanced image processing software, with no attachments required on the subject. The faceAPI® product encapsulates the core of Seeing Machines computer-vision algorithms into a package designed for licensing to OEM's and third-parties.

The flagship product faceLAB® provides an automated and contact-free gaze and head tracking technology, it solves the problem of observing human behaviour naturally, non-intrusively and with a high degree of accuracy and usability. Building on these unique face tracking and pupil measurement and monitoring capabilities, the TrueField Analyzer® is new medical device to assist clinicians detect and manage eye diseases such as glaucoma.

The TrueField Analyzer® offers a new objective method to help doctors diagnose and manage a range of eye diseases including glaucoma, age related macular degeneration and diabetic retinopathy. Glaucoma affects about 2-3% of the population over 40 years of age and is a leading source of blindness. Unlike most other devices available to the clinician the TrueField Analyzer is a completely objective test and it is quick and easy for patients and technicians alike. The device measures both eyes concurrently and due to the reliability that arises from the objective nature of the test, it has the potential to become a new standard in the measurement of visual field defects and thus in the diagnosis and management of disease such as glaucoma.

The Driver State Sensor is driver monitoring software targeted at the detection of fatigue and distraction in drivers and operators. The DSS detects drowsiness (fatigue) or that the driver is distracted and their attention has been diverted from the road, alarms are raised to alert the driver to these events. In larger deployments, such as in fleet and mining equipment operations, the data is available in both real-time and off-line modes for fleet management, driver training and awareness programs

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLGRGDIDXDGGIL
Date   Source Headline
26th Jun 20247:00 amRNSFive year License Renewal with Caterpillar
7th May 20247:00 amRNSQ3 FY2024 Quarterly KPIs
2nd May 202410:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSAutomotive Program Extension to 2032
26th Apr 202411:00 amRNSDirector/PDMR Shareholding
25th Mar 20248:06 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSHalf year results and financial report
28th Feb 20247:00 amRNSNotice of Results
8th Feb 20247:00 amRNSH1 FY2024 Trading Update & Quarterly KPIs
10th Jan 20247:00 amRNSNew Orders for Guardian Generation 3
9th Jan 20247:00 amRNSSeeing Machines unveils latest Guardian technology
3rd Jan 20247:00 amRNSSeeing Machines to showcase technology at CES 2024
20th Dec 20237:00 amRNSSeeing Machines announces US$30M European OEM win
13th Dec 20238:02 amRNSSeeing Machines welcomes U.S. NHTSA announcement
12th Dec 20237:00 amRNSSeeing Machines Wins Prestigious Road Safety Award
29th Nov 20237:57 amRNSResult of AGM
24th Nov 20237:00 amRNSAGM – reminder and correction of login details
8th Nov 20237:00 amRNS16th Automotive program awarded & Q1 FY2024 KPIs
6th Nov 202311:26 amRNSDirector/PDMR Shareholding
31st Oct 202311:50 amRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSNotice of AGM
27th Oct 20237:19 amRNSDirector/PDMR Shareholding
27th Oct 20237:13 amRNSDirector/PDMR Shareholding
25th Oct 20237:55 amRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSBoard Changes
20th Oct 20239:30 amRNSDirector/PDMR Shareholding
20th Oct 20239:21 amRNSDirector/PDMR Shareholding
19th Oct 20238:47 amRNSDirector/PDMR Shareholding
18th Oct 202310:06 amRNSDirector/PDMR Shareholding
17th Oct 20239:41 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSYear End Results – FY2023
16th Oct 20237:00 amRNSDevelopment of aviation fatigue detection solution
14th Sep 20237:00 amRNSNotice of Full Year Results 2023
7th Sep 20235:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSFY2023 Trading Update & Q4 KPIs
18th Jul 20237:30 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCEO Incentive Plan
28th Jun 20231:44 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
26th Jun 202311:38 amRNSDirector/PDMR Shareholding
23rd Jun 20238:55 amRNSDirector/PDMR Shareholding
20th Jun 20237:30 amRNSCollaboration with synthetic data specialist
19th Jun 20238:00 amRNSSeeing Machines to attend Stifel Tech Conference
25th May 20239:53 amRNSDirector/PDMR Shareholding
22nd May 20239:46 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSExclusive Agreement Signed with Collins Aerospace
4th May 20237:00 amRNSKey Performance Indicators Q3 FY2023
17th Apr 20239:29 amRNSDirector/PDMR Shareholding
13th Apr 202312:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.